Opaleye Management Inc.

13F Portfolio Filings

  • Most recent 13F
    Q4 2024
  • Location
    boston, MA
  • CIK
    0001595855
  • All SEC filings
Q4 2024
Quater
Holdings
VALUE
Top Holdings
Form Type
Date Filed
Filing Id

39

$571.42M
HROW, TG THERAPEUTICS INC, CDXS, ETON
13F-HR
Feb 14, 2025
000149315225006852

44

$599.56M
HROW, TG THERAPEUTICS INC, OCUL, ARVN
13F-HR
Nov 14, 2024
000149315224045811

51

$437.66M
HROW, TG THERAPEUTICS INC, OCUL, RYTM
13F-HR
Aug 14, 2024
000149315224032150

52

$458.86M
OCUL, HROW, TG THERAPEUTICS INC, KROS
RESTATEMENT
May 29, 2024
000149315224021780

47

$376.07M
HROW, TG THERAPEUTICS INC, ACELYRIN INC, RYTM
13F-HR
Feb 14, 2024
000149315224006653

41

$307.38M
HROW, ACELYRIN INC, OCUL, TG THERAPEUTICS INC
13F-HR
Nov 15, 2023
000149315223041364

47

$418.07M
ACELYRIN INC, HROW, OCUL, TELA
13F-HR
Aug 14, 2023
000149315223028636

41

$333.88M
HROW, OCUL, TELA, RYTM
13F-HR
May 15, 2023
000149315223016769

40

$287.57M
HROW, TELA, RYTM, OCUL
13F-HR
Feb 10, 2023
000149315223004277

42

$242.13M
HROW, OCUL, RYTM, TELA
13F-HR
Nov 14, 2022
000149315222032068

47

$221.85M
HROW, OCUL, CDXS, CRNX
13F-HR
Aug 15, 2022
000149315222022856

45

$322.00M
OCUL, CDXS, CMRX, HROW
13F-HR
May 16, 2022
000149315222013764

39

$471.49M
CDXS, OCUL, CMRX, TCE2
13F-HR
Feb 14, 2022
000149315222004434

48

$535.39M
OCUL, TCE2, CDXS, CMRX
13F-HR
Nov 16, 2021
000149315221028799

48

$602.06M
OCUL, CMRX, TCE2, BBIO
13F-HR
Aug 16, 2021
000149315221020260

58

$680.80M
OCUL, CMRX, TARA, BBIO
13F-HR
May 18, 2021
000149315221012017

59

$765.57M
OCUL, TARA, EIDX, ETON
13F-HR
Feb 12, 2021
000149315221003697

55

$511.32M
OCUL, TARA, ETON, CRDF
13F-HR
Nov 16, 2020
000149315220021694

48

$495.15M
TARA, OCUL, NEOLEUKIN THERAPEUTICS INC, CCXI
13F-HR
Aug 14, 2020
000149315220015902

44

$377.36M
ARTARA THERAPEUTICS INC, FTSV, OCUL, APTO
13F-HR
May 15, 2020
000149315220009140

47

$509.65M
EPZM, APTO, CDXS, FTSV
13F-HR
Feb 14, 2020
000149315220002529

49

$276.54M
CDXS, RJR1, EPZM, IMPRIMIS PHARMACEUTICALS INC
13F-HR
Nov 14, 2019
000149315219017503

43

$328.09M
CDXS, IMPRIMIS PHARMACEUTICALS INC, AXGN, EPZM
13F-HR
Aug 14, 2019
000149315219012567

53

$361.13M
CDXS, AXGN, EPZM, CERCEUR
13F-HR
May 15, 2019
000149315219007425

47

$267.98M
CDXS, AXGN, LOXO, EH3A
13F-HR
Feb 14, 2019
000149315219002114

47

$393.05M
AXGN, CDXS, LOXO, EH3A
13F-HR
Nov 14, 2018
000149315218016123

36

$386.36M
AXGN, LOXO, CDXS, FGEN
13F-HR
Aug 14, 2018
000149315218011830

38

$349.75M
AXGN, BPMC, LOXO, CDXS
13F-HR
May 14, 2018
000149315218006822

35

$312.30M
AXGN, BPMC, FGEN, LOXO
13F-HR
Feb 9, 2018
000149315218001743

34

$282.77M
BPMC, AXGN, FGEN, IMMU
13F-HR
Nov 14, 2017
000149315217013210

41

$239.40M
BPMC, AXGN, FGEN, LOXO
13F-HR
Aug 14, 2017
000149315217009239

44

$200.93M
BPMC, AXGN, FGEN, NVLN
13F-HR
May 15, 2017
000149315217005196

40

$169.72M
BPMC, AXGN, 1657752D, GNMX
13F-HR
Feb 21, 2017
000114420417010166

44

$191.08M
BPMC, AXGN, 1657752D, MEDGENICS INC
13F-HR
Nov 14, 2016
000154692716000542

49

$149.71M
AXGN, MEDGENICS INC, 1657752D, FGEN
RESTATEMENT
Aug 12, 2016
000154692716000514

52

$160.36M
AXGN, 1657752D, RARE, FGEN
RESTATEMENT
May 27, 2016
000154692716000499

53

$239.18M
RARE, AXGN, FGEN, GON
13F-HR
Feb 12, 2016
000154692716000408

49

$203.22M
CMRX, RARE, CEMPRA INC, AXGN
13F-HR
Nov 13, 2015
000154692715000281

46

$251.33M
CMRX, CEMPRA INC, 17R, AMAG
13F-HR
Aug 14, 2015
000154692715000231

37

$215.39M
CMRX, CEMPRA INC, 1657752D, 17R
13F-HR
May 15, 2015
000154692715000149

36

$197.90M
CMRX, AGIO, CEMPRA INC, 17R
13F-HR
Feb 13, 2015
000154692715000070

30

$128.30B
CMRX, PCYC, 17R, 1657752D
13F-HR
Nov 14, 2014
000154692714000196

27

$115.98M
CMRX, 17R, 1657752D, PCYC
13F-HR
Aug 14, 2014
000154692714000159

30

$135.37M
17R, 1657752D, CMRX, PCYC
13F-HR
May 15, 2014
000154692714000115

23

$127.39B
GENTY, GON, PCYC, 1657752D
13F-HR
Feb 14, 2014
000154692714000060